500 patients67,039 observations150 daysLIVE

Patient P-03402

Synthetic patientONX-7 · Day 144 · 75+ · F · baseline S16Steering view · 3DOpen companion preview
Therapy response
Unstable
Tolerance
Favorable
GI state
Favorable
Inflammatory state
Favorable
Nutritional resilience
Favorable
Discontinuation risk
19%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 ONX-7 startedBaseline state S16
  2. Day 29 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 29.

Primary contributors, last 14 days
  • Treatment adherence-4
  • GI instability-2
  • Toxicity+2

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Energy level
    Daily log
    5.1/10
    improving · +0.3 vs previous 14 d
    Stress level
    Daily log
    5.3/10
    improving · -0.3 vs previous 14 d
    Pessimism score
    Daily log
    5.7/10
    improving · -0.3 vs previous 14 d
    Sleep quality
    Wearable
    48.6/100
    stable · +0.8 vs previous 14 d
    Libido
    Daily log
    4.9/10
    stable · +0.2 vs previous 14 d
    HRV
    Wearable
    31.6 ms
    stable · +1.1 vs previous 14 d
    Toxicity
    Blood
    15.6/100
    worsening · +1.5 vs previous 14 d
    This trajectory is doing well — what to keep, what to watch
    Steering view →

    Heading drifting · 62 from the failing basin, 49 from restoration.

    Good elements to keep
    • Protein (supports)
      perturbation · steering +10.3
    • Butyrate producers intact
      hidden · steering +7.5
    • Protein
      supporter · GI -5 next day
    Main detractors to watch
    • Low microbial diversity
      hidden · steering -7.7
    • Poor-sleep week
      perturbation · steering -3
    • Low-HRV stretch
      perturbation · steering -2.7
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Protein
      -5supporter · 95%
    • Alcohol
      -1.6no signal · 38%
    • Dietary fat load
      -1.3no signal · 36%
    • Histamine load
      +0.6no signal · 15%
    • Caffeine
      -0.4no signal · 15%
    • Lactose
      +0.1no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Autonomic recovery 45
      • WearableResting HR 78 bpm
      • Wearable3,868 steps/day
    • Inflammatory signalling 15
      • WearableHRV 32 ms, trending down
    DNA
    Fictional pharmacogenomic panel
    • CYP2D6 Intermediate metabolizer
      Expected exposure
    • MTHFR C677T
      Reduced folate turnover
    Microbiome
    Shannon diversity 2.9 · butyrate capacity 76/100
    • Akkermansia muciniphilaNormal
    • Faecalibacterium prausnitziiNormal
    • Bacteroides fragilisNormal
    • Bifidobacterium longumNormal
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    34 ms
    Sleep
    6.6 h
    Steps
    4,161
    Resting HR
    75 bpm
    Daily log: GI score 24, nutritional resilience 61, adherence 81.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Keep fibre steady; no new sources this week
    • Avoid known triggers for now: fried or oily food, dairy, alcohol
    What to do
    • Log the daily check-in; one line is enough
    • A 15-minute walk after lunch
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the scheduled dose as agreed with your care team
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0338037%S16AD-05improved34
    P-0336936%S18AD-05no change37
    P-0303435%S14AD-05no change30
    P-0342435%S12AD-05improved41
    P-0310434%S14AD-05no change27
    P-0311134%S07AD-05no change48
    P-0312933%S18AD-05no change32
    P-0315833%S17AD-05no change37
    P-0320433%S16AD-05improved48
    P-0312230%S13AD-05no change40
    P-0344127%S19AD-05improved37
    P-0310526%S12AD-05no change60